We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+25.13%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$4.74B
AUM Growth
+$934M
Cap. Flow
+$335M
Cap. Flow %
7.07%
Top 10 Hldgs %
75.66%
Holding
73
New
12
Increased
9
Reduced
24
Closed
6

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$219M
2
BEKE icon
KE Holdings
BEKE
+$138M
3
BABA icon
Alibaba
BABA
+$69.8M
4
PDD icon
Pinduoduo
PDD
+$62.1M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$40M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$100M
2
MDLZ icon
Mondelez International
MDLZ
+$50M
3
JKS
JinkoSolar
JKS
+$30.7M
4
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
+$21.9M
5
GOSS icon
Gossamer Bio
GOSS
+$20.1M

Sector Composition

Rank Sector Weight
1 Healthcare 36.12%
2 Consumer Discretionary 33.15%
3 Technology 12.08%
4 Real Estate 6.2%
5 Materials 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TUYA
51
Tuya Inc
TUYA
$1.04B
$3.23M 0.07%
1,689,359
– –
JOYY
52
JOYY Inc
JOYY
$3.73B
$3.16M 0.07%
+100,000
New +$2.89M
MNSO icon
53
MINISO
MNSO
$3.9B
$2.71M 0.06%
252,322
– –
MRNA icon
54
Moderna
MRNA
$21.7B
$2.69M 0.06%
+15,000
New +$2.45M
IPSC icon
55
Century Therapeutics
IPSC
$364M
$2.55M 0.05%
496,624
-117,471
-19% -$1.11M
BEDU
56
DELISTED
Bright Scholar Education Holdings
BEDU
$2.41M 0.05%
996,449
– –
ALGS icon
57
Aligos Therapeutics
ALGS
$26.1M
$2.2M 0.05%
92,391
-2,212
-2% -$55.8K
MOGU
58
MOGU Inc
MOGU
$17.3M
$2.15M 0.05%
870,580
– –
PATH icon
59
UiPath
PATH
$6.5B
$1.85M 0.04%
145,200
-4,800
-3% -$59.3K
CCC
60
CCC Intelligent Solutions
CCC
$3.57B
$1.74M 0.04%
200,000
– –
RDGT
61
Ridgetech Inc
RDGT
$818K
$1.43M 0.03%
134
– –
PYXS icon
62
Pyxis Oncology
PYXS
$191M
$1.02M 0.02%
764,406
– –
SRZN icon
63
Surrozen
SRZN
$216M
$676K 0.01%
77,427
-2,573
-3% -$54.4K
ROOT icon
64
Root
ROOT
$908M
$624K 0.01%
138,977
-5,466
-4% -$37.7K
UXIN
65
Uxin Ltd
UXIN
$301M
$552K 0.01%
19,156
– –
DLO icon
66
dLocal
DLO
$4.27B
$106K ﹤0.01%
6,800
-373,724
-98% -$6.57M
SRZNW icon
67
Surrozen Inc Warrant
SRZNW
$36.6K
$26.4K ﹤0.01%
399,999
– –
ACMR icon
68
ACM Research
ACMR
$4.56B
– –
-670,755
Closed -$8.36M
ADCT icon
69
ADC Therapeutics
ADCT
$140M
– –
-500,000
Closed -$2.41M
MP icon
70
MP Materials
MP
$6.93B
– –
-200,000
Closed -$5.46M
OIH icon
71
VanEck Oil Services ETF
OIH
$1.98B
– –
-20,000
Closed -$4.22M
PRLD icon
72
Prelude Therapeutics
PRLD
$364M
– –
-583,333
Closed -$3.86M
FMTX
73
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-1,100,000
Closed -$21.9M
1 2
3

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, HHLR Advisors held 73 positions worth $4.74B, up 25% from $3.8B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

HHLR Advisors deployed $335M of net new capital in Q4 2022, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was Freeport-McMoran: 6,274,800 shares worth $238M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Salesforce, an estimated $100M trimmed.

  • HHLR Advisors's largest Q4 2022 buy was Freeport-McMoran: 6,274,800 shares worth $238M.
  • HHLR Advisors added most to KE Holdings in Q4 2022, an estimated $138M increase.
  • HHLR Advisors's biggest Q4 2022 reduction was Salesforce, cutting an estimated $100M.
  • HHLR Advisors fully exited Forma Therapeutics Holdings, Inc. Common Stock in Q4 2022, selling an estimated $21.9M.
  • HHLR Advisors's ten largest holdings make up 76% of its $4.74B portfolio in Q4 2022.
  • HHLR Advisors opened 12 new positions and closed 6 in Q4 2022.
  • HHLR Advisors's portfolio value rose 25% quarter-over-quarter to $4.74B.

Based on HHLR Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.